TY - JOUR
T1 - A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy
AU - Newmaster, Kyra
AU - Zhu, Zahra
AU - Bolt, Elizabeth
AU - Chang, Ryan J.
AU - Day, Christopher
AU - Mhanna, Asmaa
AU - Paudel, Sita
AU - Farooq, Osman
AU - Swaminathan, Arun
AU - Acharya, Prakrati
AU - Cheungpasitporn, Wisit
AU - Gupta, Siddharth
AU - Samanta, Debopam
AU - Mahfooz, Naeem
AU - Mainali, Gayatra
AU - Carney, Paul R.
AU - Naik, Sunil
N1 - Publisher Copyright:
© 2022 by the authors.
PY - 2022/9
Y1 - 2022/9
N2 - Ketogenic diets (KDs) are highly effective in the treatment of epilepsy. However, numerous complications have been reported. During the initiation phase of the diet, common side effects include vomiting, hypoglycemia, metabolic acidosis and refusal of the diet. While on the diet, the side effects involve the following systems: gastrointestinal, hepatic, cardiovascular, renal, dermatological, hematologic and bone. Many of the common side effects can be tackled easily with careful monitoring including blood counts, liver enzymes, renal function tests, urinalysis, vitamin levels, mineral levels, lipid profiles, and serum carnitine levels. Some rare and serious side effects reported in the literature include pancreatitis, protein-losing enteropathy, prolonged QT interval, cardiomyopathy and changes in the basal ganglia. These serious complications may need more advanced work-up and immediate cessation of the diet. With appropriate monitoring and close follow-up to minimize adverse effects, KDs can be effective for patients with intractable epilepsy.
AB - Ketogenic diets (KDs) are highly effective in the treatment of epilepsy. However, numerous complications have been reported. During the initiation phase of the diet, common side effects include vomiting, hypoglycemia, metabolic acidosis and refusal of the diet. While on the diet, the side effects involve the following systems: gastrointestinal, hepatic, cardiovascular, renal, dermatological, hematologic and bone. Many of the common side effects can be tackled easily with careful monitoring including blood counts, liver enzymes, renal function tests, urinalysis, vitamin levels, mineral levels, lipid profiles, and serum carnitine levels. Some rare and serious side effects reported in the literature include pancreatitis, protein-losing enteropathy, prolonged QT interval, cardiomyopathy and changes in the basal ganglia. These serious complications may need more advanced work-up and immediate cessation of the diet. With appropriate monitoring and close follow-up to minimize adverse effects, KDs can be effective for patients with intractable epilepsy.
UR - http://www.scopus.com/inward/record.url?scp=85138578433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138578433&partnerID=8YFLogxK
U2 - 10.3390/children9091372
DO - 10.3390/children9091372
M3 - Review article
C2 - 36138681
AN - SCOPUS:85138578433
SN - 2227-9067
VL - 9
JO - Children
JF - Children
IS - 9
M1 - 1372
ER -